197 related articles for article (PubMed ID: 20443189)
1. CTLA4-Ig inhibits allergic airway inflammation by a novel CD28-independent, nitric oxide synthase-dependent mechanism.
Deppong CM; Parulekar A; Boomer JS; Bricker TL; Green JM
Eur J Immunol; 2010 Jul; 40(7):1985-94. PubMed ID: 20443189
[TBL] [Abstract][Full Text] [Related]
2. The role of co-stimulation in airway inflammation.
Djukanovic R
Clin Exp Allergy; 2000 Jun; 30 Suppl 1():46-50. PubMed ID: 10849475
[TBL] [Abstract][Full Text] [Related]
3. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen.
Burr JS; Kimzey SL; Randolph DR; Green JM
Am J Respir Cell Mol Biol; 2001 May; 24(5):563-8. PubMed ID: 11350825
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
5. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis.
Israël-Assayag E; Fournier M; Cormier Y
J Immunol; 1999 Dec; 163(12):6794-9. PubMed ID: 10586079
[TBL] [Abstract][Full Text] [Related]
6. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens.
Keane-Myers A; Gause WC; Linsley PS; Chen SJ; Wills-Karp M
J Immunol; 1997 Mar; 158(5):2042-9. PubMed ID: 9036947
[TBL] [Abstract][Full Text] [Related]
7. CD28-specific antibody prevents graft-versus-host disease in mice.
Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CD28/CTLA4-B7 costimulatory pathway in the development of lymphadenopathy and splenomegaly in MRL/lpr mice.
Takiguchi M; Murakami M; Nakagawa I; Rashid MM; Tosa N; Chikuma S; Hashimoto A; Uede T
J Vet Med Sci; 2000 Jan; 62(1):29-36. PubMed ID: 10676886
[TBL] [Abstract][Full Text] [Related]
9. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
10. CTLA4-Ig: a novel immunosuppressive agent.
Najafian N; Sayegh MH
Expert Opin Investig Drugs; 2000 Sep; 9(9):2147-57. PubMed ID: 11060799
[TBL] [Abstract][Full Text] [Related]
11. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function.
Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y
J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CD28/B7 interaction suppresses allergic eosinophilic inflammation in mice.
Kasai M; Kumano K; Kurasawa K; Nakao A; Saito Y; Iwamoto I
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():14-9. PubMed ID: 9758890
[TBL] [Abstract][Full Text] [Related]
13. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Fallarino F; Fields PE; Gajewski TF
J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
[TBL] [Abstract][Full Text] [Related]
14. CD28/CTLA4 double deficient mice demonstrate crucial role for B7 co-stimulation in the induction of allergic lower airways disease.
Deurloo DT; van Berkel MA; van Esch BC; Hofhuis F; Nijkamp FP; Oosterwegel MA; van Oosterhout AJ
Clin Exp Allergy; 2003 Sep; 33(9):1297-304. PubMed ID: 12956753
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of CTLA-4-Ig in tolerance induction.
Alegre ML; Fallarino F
Curr Pharm Des; 2006; 12(2):149-60. PubMed ID: 16454732
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.
Kurlberg G; Haglind E; Schön K; Törnqvist H; Lycke N
Scand J Immunol; 2000 Mar; 51(3):224-30. PubMed ID: 10736090
[TBL] [Abstract][Full Text] [Related]
17. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
18. Absence of B7-dependent responses in CD28-deficient mice.
Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
[TBL] [Abstract][Full Text] [Related]
19. CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β.
Deppong CM; Bricker TL; Rannals BD; Van Rooijen N; Hsieh CS; Green JM
J Immunol; 2013 Sep; 191(6):3082-9. PubMed ID: 23956428
[TBL] [Abstract][Full Text] [Related]
20. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]